Global Animal Model Market

Global Animal Model Market Size, Share, Growth Analysis, By Type(Pigs, Cats), By Application(Research and Development, Production) - Industry Forecast 2023-2030


Report ID: SQMIG35A2418 | Region: Global | Published Date: July, 2030 | Pages: 219 | Tables: 63 | Figures: 75

Global Animal Model Market Insights

Global Animal model Market size was valued at USD 2.26 Billion in 2022 and is poised to grow from USD 2.44 Billion in 2023 to USD 4.44 Billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The purpose of the animal model market is to provide researchers with reliable and representative models that closely mimic human physiology and pathophysiology. The driving factors for the growth of the animal model market is the increasing prevalence of chronic and complex diseases, such as cancer, cardiovascular disorders, and neurological conditions. The animal model market presents significant opportunities. The development of genetically modified animal models, such as transgenic mice, allows researchers to study specific genes and their role in disease progression. Additionally, the rising demand for personalized medicine and the need for tailored therapies open opportunities for the development of patient-derived animal models and precision medicine approaches.

The global animal model market plays a crucial role in advancing scientific knowledge and drug development. While facing challenges such as ethical concerns and the emergence of alternative technologies, the market continues to provide valuable tools for understanding diseases and developing new treatments. The ongoing development of innovative animal models and the growing need for personalized medicine present opportunities for further growth and advancement in this field.

US Animal Model Market is poised to grow at sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 2.26 Billion

Largest Segment

Mice

Fastest Growth

Mice

Growth Rate

7.8% CAGR

Global Animal Model Market ($ Bn)
Country Share for North America Region (%)
Global Animal Model Market By Type ($ Bn)
Global Animal Model Market By Type (%)

To get more reports on the above market click here to Buy The Report

Global Animal Model Market Segmental Analysis

The global animal model market is segmented on the basis of type, application, and region. Based on type, the market is segmented into pigs, cats, and mice. By Application, the market is segmented into research and development, production, and quality control. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Animal model Market Analysis by Type

Mice dominate the market, accounting for the largest share in 2022. Mice have long been the primary animal model for biomedical research due to their genetic similarity to humans, ease of handling, and relatively low cost. Their small size allows for efficient breeding and maintenance, making them highly suitable for large-scale studies. Mice are versatile models that can be genetically modified to mimic human diseases, enabling researchers to gain valuable insights into various conditions. With a market share of over 50%, mice hold a significant position in the animal model market.

The fastest growing segment in the animal model market is pigs. Pigs are gaining prominence as an animal model due to their physiological similarities to humans in terms of organ size, metabolism, and immunological responses. Pigs serve as valuable models for studying complex diseases and evaluating novel therapies. They are particularly relevant in research areas such as cardiovascular diseases, obesity, diabetes, and gastrointestinal disorders. The demand for pig models is rising steadily, driven by the need to bridge the gap between small animal models and human clinical trials. With a robust growth rate and increasing research applications, the pig segment is poised to be the fastest growing in the animal model market.

Animal model Market Analysis by Application

The largest segment of 2022 is Research and Development (R&D). R&D accounts for the largest share in the market due to the extensive use of animal models in preclinical research and development of new drugs, therapies, and medical devices. Animal models play a vital role in understanding disease mechanisms, evaluating the safety and efficacy of potential treatments, and conducting in-depth studies on biological processes. The R&D segment, with its significant contribution to scientific advancements, holds a dominant position in the animal model market.

The fastest growing segment in the animal model market is Quality Control. Quality control refers to the application of animal models in ensuring the safety, efficacy, and quality of pharmaceutical products, medical devices, and biological materials. Animal models are used to assess product quality, conduct toxicity testing, and ensure compliance with regulatory standards. With increasing regulatory requirements and the need for stringent quality control measures in the pharmaceutical and healthcare industries, the demand for animal models in quality control applications is expected to grow rapidly. The Quality Control segment is characterized by its rising significance in maintaining product standards and ensuring patient safety.

Global Animal Model Market By Type, 2022 (%)

To get detailed analysis on other segments, Request For Sample Report

Global Animal Model Market Regional Insights

North America emerges as the dominating region in 2022. The region's dominance can be attributed to several factors, including a strong research infrastructure, a well-established pharmaceutical and biotechnology industry, and significant investments in biomedical research. The presence of leading research institutions, universities, and pharmaceutical companies in countries like the United States and Canada contributes to North America's prominence in the animal model market. Moreover, favorable government initiatives and funding for research activities further support the growth of the market in the region.

Asia Pacific is expected to be the fastest growing region in the animal model market. The region's rapid growth can be attributed to various factors, including the increasing focus on biomedical research, rising investments in healthcare infrastructure, and a growing demand for novel therapies. Countries such as China, India, Japan, and South Korea are witnessing significant advancements in biomedical research and development, leading to an increased demand for animal models. Additionally, the presence of a large population base and the prevalence of chronic diseases in the region contribute to the growth of the animal model market in Asia Pacific.

Global Animal Model Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Animal Model Market Dynamics

Animal model Market Drivers

Increasing Demand for Personalized Medicine

  • With advancements in genomics and precision medicine, there is a need for animal models that can accurately represent individual patient characteristics and response to treatments. Researchers and pharmaceutical companies are increasingly utilizing animal models to study specific genetic variations and develop targeted therapies. For example, the development of patient-derived xenograft (PDX) models, where patient tumor samples are implanted into animals for drug testing, gained momentum in 2022. These models allow researchers to evaluate the efficacy of treatments tailored to individual patients, driving the demand for animal models in personalized medicine.

Advancements in Gene Editing Technologies

  • Another driver in the animal model market in 2022 was the rapid advancement of gene editing technologies, such as CRISPR-Cas9. These technologies allow for precise manipulation of genes in animal models, enabling the creation of genetically modified models that closely mimic human diseases. Researchers can introduce specific genetic mutations or modifications in animal models to study the underlying mechanisms of diseases and develop novel therapeutics. The widespread adoption of gene editing technologies in 2022 contributed to the increased utilization of animal models and drove innovation in the field.

Animal model Market Restraints

Ethical Concerns and Animal Welfare

  • Despite the significant advancements in the animal model field, ethical concerns and animal welfare remained a major restraint in 2022. The use of animals in research raises ethical questions and prompts debates about the humane treatment of animals. Animal welfare regulations and public scrutiny have led to increased scrutiny of the use of animal models, particularly in countries with stringent animal welfare regulations. These concerns and regulations pose challenges to the expansion of the animal model market and encourage the development of alternative technologies and models.

High Costs and Complexities

  • The high costs associated with maintaining animal facilities, purchasing and breeding animals, and conducting experiments with animal models presented a restraint in the market in 2022. Animal models require dedicated facilities, specialized care, and resources, making them expensive to maintain. Additionally, the complexities involved in working with animal models, such as the need for experienced personnel, regulatory compliance, and logistical challenges, add to the overall costs. These cost and complexity factors can limit the accessibility and utilization of animal models, especially for smaller research organizations with limited budgets.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Animal Model Market Competitive Landscape

The global animal model market is highly competitive and comprises of several key players vying for market share. These companies engage in extensive research and development activities to develop innovative animal models and services to cater to the evolving needs of the pharmaceutical, biotechnology, and academic research sectors. Additionally, strategic collaborations, mergers, and acquisitions are commonly observed in the market as companies aim to strengthen their market presence and expand their product portfolios. The competitive landscape of the animal model market is characterized by intense competition, technological advancements, and a focus on customer-centric solutions. Market players strive to differentiate themselves through high-quality products, comprehensive service offerings, and strong customer support. With the growing demand for reliable and predictive animal models in drug discovery and development, these companies continue to play a crucial role in driving advancements in biomedical research and contributing to the overall growth of the animal model market.

Animal model Market Top Player’s Company Profiles

  • Charles River Laboratories International Inc. (US)
  • Envigo (US)
  • genOway SA (France)
  • Horizon Discovery Group plc (UK)
  • TransGenic Inc. (Japan)
  • Janvier Labs (France)
  • Laboratory Corporation of America Holdings (US)
  • Harbour Antibodies BV (Netherlands)
  • Eurofins Scientific (Luxembourg)
  • Biocytogen LLC (US)
  • Transnetyx Inc. (US)
  • Ingenious Targeting Laboratory (US)
  • Charles River Japan (Japan)
  • Cyagen Biosciences Inc. (US)
  • Ozgene Pty Ltd (Australia)
  • Hera Biolabs Inc. (US)
  • Pharmaron Beijing Co., Ltd. (China)

Animal model Market Recent Developments

  • In March 2022, Charles River Laboratories International Inc., a prominent player in the animal model market, announced the acquisition of Distributed Bio, Inc., a biotechnology company specializing in the discovery and optimization of therapeutic antibodies. This acquisition aimed to enhance Charles River's capabilities in antibody discovery and engineering, providing comprehensive solutions to its customers.
  • In January 2022, Taconic Biosciences, a leading provider of animal models and services, announced the expansion of its humanized mouse model portfolio. The company introduced new models that incorporate human immune systems for improved preclinical research in immuno-oncology and infectious diseases.
  • In October 2021, Horizon Discovery Group plc, a company specializing in the application of gene editing and gene modulation technologies, announced the launch of its next-generation rodent model generation platform. This platform utilizes advanced CRISPR-Cas9 technology to develop precise and complex animal models for research purposes.

Global Animal Model Key Market Trends

  • Shift towards Humanized and Translational Models: A key trend observed in the animal model market in 2022 was the increasing focus on humanized and translational models. Researchers are striving to develop animal models that closely mimic human physiology, disease progression, and drug responses. This trend involves the incorporation of human cells, tissues, or genetic modifications into animal models to enhance their relevance to human diseases. For example, the development of humanized mice with a human immune system allows for better studying of immune-related diseases and testing of immunotherapies. The shift towards humanized and translational models in 2022 highlights the industry's aim to improve the predictability and applicability of animal models in human disease research.

Global Animal Model Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global animal model market analysis, animal models, such as mice, cats, and pigs, are widely used to study various diseases, test new drugs and therapies, and gain insights into human biology. The market analysis of the animal model industry involves studying factors like market size, growth trends, key players, and market dynamics. The market for animal models has been witnessing steady growth due to several factors. One of the driving factors is the increasing demand for effective treatment options for human diseases. Animal models provide valuable insights into disease mechanisms and help researchers develop and test potential treatments.

Advancements in genetic engineering technologies have led to the creation of genetically modified animal models that closely mimic human diseases, further driving the market growth. The animal model market presents significant opportunities for growth. The increasing focus on personalized medicine and the development of targeted therapies require the use of precise animal models. Moreover, the rising investments in biomedical research and the expanding pharmaceutical and biotechnology industries are driving the demand for animal models. The global animal model market plays a crucial role in biomedical research and drug development. It is driven by the need for better disease understanding and therapeutic advancements. While facing challenges and ethical considerations, the market offers significant opportunities for growth and innovation, with emerging trends shaping the future of animal models in scientific research.

Report Metric Details
Market size value in 2022 USD 2.26 Billion
Market size value in 2031 USD 4.44 Billion
Growth Rate 7.8%
Base year 2022
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Pigs, Cats, and Mice
  • Application
    • Research and Development, Production, and Quality Control
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Charles River Laboratories International Inc. (US)
  • Envigo (US)
  • genOway SA (France)
  • Horizon Discovery Group plc (UK)
  • TransGenic Inc. (Japan)
  • Janvier Labs (France)
  • Laboratory Corporation of America Holdings (US)
  • Harbour Antibodies BV (Netherlands)
  • Eurofins Scientific (Luxembourg)
  • Biocytogen LLC (US)
  • Transnetyx Inc. (US)
  • Ingenious Targeting Laboratory (US)
  • Charles River Japan (Japan)
  • Cyagen Biosciences Inc. (US)
  • Ozgene Pty Ltd (Australia)
  • Hera Biolabs Inc. (US)
  • Pharmaron Beijing Co., Ltd. (China)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Animal Model Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Animal Model Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Animal Model Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Animal Model Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Animal Model Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Animal Model Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Global Animal model Market size was valued at USD 2.26 Billion in 2022 and is poised to grow from USD 2.44 Billion in 2023 to USD 4.44 Billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The global animal model market is highly competitive and comprises of several key players vying for market share. These companies engage in extensive research and development activities to develop innovative animal models and services to cater to the evolving needs of the pharmaceutical, biotechnology, and academic research sectors. Additionally, strategic collaborations, mergers, and acquisitions are commonly observed in the market as companies aim to strengthen their market presence and expand their product portfolios. The competitive landscape of the animal model market is characterized by intense competition, technological advancements, and a focus on customer-centric solutions. Market players strive to differentiate themselves through high-quality products, comprehensive service offerings, and strong customer support. With the growing demand for reliable and predictive animal models in drug discovery and development, these companies continue to play a crucial role in driving advancements in biomedical research and contributing to the overall growth of the animal model market. 'Charles River Laboratories International Inc. (US)', 'Envigo (US)', 'The Jackson Laboratory (US)', 'Taconic Biosciences Inc. (US)', 'genOway SA (France)', 'Horizon Discovery Group plc (UK)', 'TransGenic Inc. (Japan)', 'Crown Bioscience Inc. (US)', 'Janvier Labs (France)', 'Laboratory Corporation of America Holdings (US)', 'Harbour Antibodies BV (Netherlands)', 'Eurofins Scientific (Luxembourg)', 'Biocytogen LLC (US)', 'Transnetyx Inc. (US)', 'Ingenious Targeting Laboratory (US)', 'Charles River Japan (Japan)', 'Cyagen Biosciences Inc. (US)', 'Ozgene Pty Ltd (Australia)', 'Hera Biolabs Inc. (US)', 'Pharmaron Beijing Co., Ltd. (China)'

With advancements in genomics and precision medicine, there is a need for animal models that can accurately represent individual patient characteristics and response to treatments. Researchers and pharmaceutical companies are increasingly utilizing animal models to study specific genetic variations and develop targeted therapies. For example, the development of patient-derived xenograft (PDX) models, where patient tumor samples are implanted into animals for drug testing, gained momentum in 2022. These models allow researchers to evaluate the efficacy of treatments tailored to individual patients, driving the demand for animal models in personalized medicine.

Shift towards Humanized and Translational Models: A key trend observed in the animal model market in 2022 was the increasing focus on humanized and translational models. Researchers are striving to develop animal models that closely mimic human physiology, disease progression, and drug responses. This trend involves the incorporation of human cells, tissues, or genetic modifications into animal models to enhance their relevance to human diseases. For example, the development of humanized mice with a human immune system allows for better studying of immune-related diseases and testing of immunotherapies. The shift towards humanized and translational models in 2022 highlights the industry's aim to improve the predictability and applicability of animal models in human disease research.

North America emerges as the dominating region in 2022. The region's dominance can be attributed to several factors, including a strong research infrastructure, a well-established pharmaceutical and biotechnology industry, and significant investments in biomedical research. The presence of leading research institutions, universities, and pharmaceutical companies in countries like the United States and Canada contributes to North America's prominence in the animal model market. Moreover, favorable government initiatives and funding for research activities further support the growth of the market in the region.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Animal Model Market

Product ID: SQMIG35A2418

$5,300
BUY NOW GET SAMPLE